Clascoterone and RU-58841 Interaction
Clascoterone and RU-58841 have an interaction requiring monitoring for interaction with 90% confidence. Both clascoterone and RU-58841 are androgen receptor antagonists applied topically to block DHT at the follicle. Using both simultaneously provides overlapping rather than complementary mechanisms and could increase the risk of local irritation or, theoretically, additive anti-androgenic effects if absorption occurs. There is no clinical rationale for combining two topical AR antagonists; one or the other is recommended. Both compounds affect the skin, so monitoring these systems is recommended.
Compound Profiles
Clascoterone
Topical Androgen Receptor Inhibitor | Acne & Hair Loss
Clascoterone acts as a competitive antagonist of the androgen receptor (AR). When applied topically, it penetrates the skin and binds directly to androgen receptors in target tissues -- sebaceous glands (for acne) and dermal papilla cells of hair follicles (for alopecia).
View full profileRU-58841
Topical Anti-Androgen | Experimental Hair Loss Treatment
RU-58841 functions as a competitive antagonist of the androgen receptor (AR). When applied topically to the scalp, it penetrates the skin and binds directly to androgen receptors in dermal papilla cells of hair follicles, preventing dihydrotestosterone (DHT) and testosterone from activating those receptors.
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Clascoterone with RU-58841?
Yes, but with caution. Both clascoterone and RU-58841 are androgen receptor antagonists applied topically to block DHT at the follicle. Using both simultaneously provides overlapping rather than complementary mechanisms and could increase the risk of local irritation or, theoretically, additive anti-androgenic effects if absorption occurs. There is no clinical rationale for combining two topical AR antagonists; one or the other is recommended. Regular monitoring is advised.
Is Clascoterone and RU-58841 safe together?
Based on documented research, this combination is considered monitor. However, shared safety flags include: teratogenic. Monitor accordingly.
What are the interactions between Clascoterone and RU-58841?
Both clascoterone and RU-58841 are androgen receptor antagonists applied topically to block DHT at the follicle. Using both simultaneously provides overlapping rather than complementary mechanisms and could increase the risk of local irritation or, theoretically, additive anti-androgenic effects if absorption occurs. There is no clinical rationale for combining two topical AR antagonists; one or the other is recommended. This assessment has 90% confidence and is based on documented research data.
How should I time Clascoterone and RU-58841?
Clascoterone has a half-life of Short topical (local action; rapidly metabolized to cortexolone) and RU-58841 has a half-life of ~1 hour topically (very short systemic half-life). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.